Skip To Main Content
Barbara Ficarra on Muck Rack

Barbara Ficarra

New York
As seen in: CNN, HuffPost, Phys.org, University of Rochester, Medical Xpress, Healthworks Collective, The Podcast by KevinMD
RN|Writer|Int Spkr|Textbook Author #VR|Multimedia|Health Designer™|#Wellbeing team level 1 trauma ctr|frm @HuffPost #health #wellness #healthydesign @healthin30
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

T cell protein could unlock new treatment for the most-feared joint replacement complication

|
By Barbara Ficarra, Sadie Harley, Robert Egan Verified
| Medical Xpress Verified
Graphical abstract. Credit: Communications Medicine (2026). DOI: 10.1038/s43856-026-01835-9 Bone and joint infections cause significant health problems for patients and lead to millions of dollars in added health costs per year, but clinicians lack reliable tools to predict which patients will develop severe or persistent disease. And when standard-of-care antibiotics fall short, there are no immunotherapies available to help patients mount a stronger defense against infections.
Open in Who Shared Issue with article?

Researchers Discover Common Culprit in Worst Bone Infections

|
By Barbara Ficarra
| University of Rochester
Key Findings Bone and joint infections are a serious health concern, but clinicians lack reliable tools to predict which patients will develop severe or persistent disease When antibiotics fail, there are no immunotherapies to help fight these infections Researchers have identified a T cell protein as a common factor in the most severe bone infections This could help physicians better predict who will suffer the worst cases, and may offer a new treatment option: drugs already shown to boost T...
Open in Who Shared Issue with article?

Women With Polyendocrine Metabolic Ovarian Syndrome Have Higher Cardiac Events Risk

|
By Barbara Ficarra
| University of Rochester
Key findings: Women with polyendocrine metabolic ovarian syndrome (PMOS) are four times more likely to have atherosclerotic cardiovascular disease events, including heart attacks and strokes, than those without the condition.
Open in Who Shared Issue with article?
See all 58 licensed articles (67 Total)